scispace - formally typeset
Journal ArticleDOI

Upper Urinary Tract Carcinoma in Lynch Syndrome Cases

Reads0
Chats0
TLDR
Upper urinary tract tumors develop at a younger age and are more likely to be in the ureter with an almost equal gender ratio in patients with Lynch syndrome, which has high grade potential similar to that in the general population.
About
This article is published in The Journal of Urology.The article was published on 2011-05-01. It has received 72 citations till now. The article focuses on the topics: Lynch syndrome & Upper urinary tract.

read more

Citations
More filters
Journal ArticleDOI

Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma.

TL;DR: Mutations in UTUC occur at differing frequencies from bladder cancer, with four unique molecular and clinical subtypes with distinct behaviors, including a novel SH3KBP1-CNTNAP5 fusion.
Journal ArticleDOI

Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.

TL;DR: Cancers of the upper urinary tract and the urinary bladder are included in the Lynch syndrome tumor spectrum, which suggest that surveillance should be targeted at individuals with mutations herein.
Journal ArticleDOI

Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

TL;DR: MLH1 and PMS2 testing appear to have little utility in upper tract urothelial carcinoma; however, mismatch repair protein loss of MSH2 and/or MSH6 by immunohistochemistry seems relatively sensitive and specific for identifying patients with potential Lynch syndrome.
Journal ArticleDOI

The genetic basis of Lynch syndrome and its implications for clinical practice and risk management

TL;DR: The history of Lynch Syndrome, the current knowledge of genotype–phenotype correlations, the cancers associated with Lynch syndrome, and management of individuals who are gene carriers are reviewed.
References
More filters
Journal ArticleDOI

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

TL;DR: A randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma found the rate of complete response was significantly higher in the group that received CHOP plus r ituximabs than in thegroup that receivedCHOP alone.
Journal ArticleDOI

Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma

TL;DR: Data support the hypothesis that ADCC plays an important role in the clinical effect of rituximab at the level of the effector cell.
Journal ArticleDOI

Extracolonic Cancer in Hereditary Nonpolyposis Colorectal Cancer

TL;DR: This work has shown that in some but not all families with hereditary nonpolyposis colorectal cancer there is a high risk of certain cancers other than colon cancer.
Journal ArticleDOI

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients

TL;DR: Primary tumor stage and surgical procedure performed (radical versus parenchymal sparing) are important predictors of disease recurrence and survival in patients treated for upper tract transitional cell carcinoma with extended follow-up.
Journal ArticleDOI

The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome

TL;DR: Urologic tract cancer and ovarian cancer occur frequently enough in some LS subgroups to justify trials to evaluate promising prevention interventions, and other cancer types studied occur too infrequently to justify strenuous cancer control interventions.
Related Papers (5)